Research Impact

h-index

N/A

Research impact score

Publications

Total publications

Trial Results

Published trial results

Citations

Total citations

Drug Portfolio

DRUG(8)

MIXED(6)

Clarithromycin

3 trials

phase_1

mylan-pharmaceuticals-inc

CelexaTM 40 mg tablets, single dose

Citalopram HBr 40 mg tablets, single dose

1 trial

phase_1

actavis-inc

GIC-1002 345 mg TID (equimolar to GIC-1001 375 mg TID)

1 trial

phase_1

gicare-pharma-inc

GIC-1002 460 mg (equimolar to GIC-1001 500 mg)

+2 more interventions

10 unique interventions2 categories

Analytics

Trial Phases

Phase 110

Trial Status

Completed10

Role Distribution

Principal Investigator10

PI Rate100%

Activity Timeline

Clinical Trials (10)

NCT05145621Phase 1Completed

Oral Bio-equivalence Study

BioequivalenceSafety

PrincipalinvestigatorStart date: 2015-10-29

NCT04623034Phase 1Completed

Evaluation of the Safety and Pharmacokinetics of MSI-195 to a Commercial S-Adenosylmethionine

Major Depressive Disorder

PrincipalinvestigatorStart date: 2013-04-17

NCT00648128Phase 1Completed

Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fed State

Healthy

Principalinvestigator

NCT00648830Phase 1Completed

Comparative Bioavailability Study of Clarithromycin 250 mg Tablets

Healthy

Principalinvestigator

NCT00648960Phase 1Completed

Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fasting State

Healthy

Principalinvestigator

NCT00864890Phase 1Completed

A Relative Bioavailability Study of Citalopram 40 mg Tablets Under Fed Conditions

Healthy

Principalinvestigator

NCT00905190Phase 1Completed

Bioavailability Study of Anti Nausea Medication With and Without Food

Nausea

Principalinvestigator

NCT00981487Phase 1Completed

Bioavailability Study of Anti Nausea Medication With and Without Food (EUR-1025)

Nausea

Principalinvestigator

NCT01036854Phase 1Completed

Pharmacokinetic Study of Ondansetron Administered as IR (Zofran) and MR (EUR1025)

Nausea

Principalinvestigator

NCT02276768Phase 1Completed

Study on Analgesia of GIC-1001 & GIC-1002 on Visceral Pain, Rectal Sensory Threshold Using the Barostat Method

CancerColonic DiseasePain

Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Healthy4 Nausea3 Therapeutic Equivalency1 Cancer1 Colonic Diseases1 Major Depressive Disorder1 Pain1 Safety1

Affiliations

Algorithme Pharma Inc

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

emilie garrido pradalie

APHM

35 trials

Shared therapeutic areas:

CancerHealthy

Similarity Score8%

Sabine Hazan, MD

ProgenaBiome

41 trials

Shared therapeutic areas:

Major Depressive DisorderCancer

Similarity Score8%

Murad Alam, MD

Northwestern University

65 trials

Shared therapeutic areas:

PainHealthy

Similarity Score8%

Aminah Jatoi, MD

Mayo Clinic

29 trials

Shared therapeutic areas:

CancerPain

Similarity Score8%

Jose CA Carvalho, MD

MOUNT SINAI HOSPITAL

27 trials

Shared therapeutic areas:

PainNausea

Similarity Score8%

Robert B Innis, M.D.

National Institute of Mental Health (NIMH)

35 trials

Shared therapeutic areas:

HealthyMajor Depressive Disorder

Similarity Score8%

Daniel i Sessler, MD

The Cleveland Clinic

26 trials

Shared therapeutic areas:

PainNausea

Similarity Score8%

loic MONDOLONI

Assistance Publique Hopitaux De Marseille

28 trials

Shared therapeutic areas:

Cancer

Similarity Score4%

Waqar ahmed awan, Phd

Riphah International University

20 trials

Shared therapeutic areas:

Healthy

Similarity Score4%

Hagop Youssoufian, MD

Verastem, Inc.

20 trials

Shared therapeutic areas:

Healthy

Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (10)

Showing 10 of 10 trials

NCT05145621Phase 1PrincipalInvestigator

Oral Bio-equivalence Study

BioequivalenceSafety

Completed

NCT04623034Phase 1PrincipalInvestigator

Evaluation of the Safety and Pharmacokinetics of MSI-195 to a Commercial S-Adenosylmethionine

Major Depressive Disorder

Completed

NCT00648128Phase 1PrincipalInvestigator

Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fed State

Healthy

Completed

NCT00648830Phase 1PrincipalInvestigator

Comparative Bioavailability Study of Clarithromycin 250 mg Tablets

Healthy

Completed

NCT00648960Phase 1PrincipalInvestigator

Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fasting State

Healthy

Completed

NCT00864890Phase 1PrincipalInvestigator

A Relative Bioavailability Study of Citalopram 40 mg Tablets Under Fed Conditions

Healthy

Completed

NCT00905190Phase 1PrincipalInvestigator

Bioavailability Study of Anti Nausea Medication With and Without Food

Nausea

Completed

NCT00981487Phase 1PrincipalInvestigator

Bioavailability Study of Anti Nausea Medication With and Without Food (EUR-1025)

Nausea

Completed

NCT01036854Phase 1PrincipalInvestigator

Pharmacokinetic Study of Ondansetron Administered as IR (Zofran) and MR (EUR1025)

Nausea

Completed

NCT02276768Phase 1PrincipalInvestigator

Study on Analgesia of GIC-1001 & GIC-1002 on Visceral Pain, Rectal Sensory Threshold Using the Barostat Method

CancerColonic DiseasePain

Completed

All 10 trials loaded